RxDoctor Payments DataLook up a doctor →

Eric Prystowsky, MD

Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1306815964

Payments from drug & device makers

$1,139,808in general payments, 2019–2025

Across 428 payments — averaging $2663.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$828K
  • Philips North America LLC$137K
  • Braemar Manufacturing, LLC$130K
  • Boston Scientific$20K
  • Biotronik Inc.$13K
  • Topera, Inc.$11K
  • plus $179 from 2 others

What the payments were for

  • Consulting fees$286,89925%
  • Speaking & faculty fees$762,92567%
  • Travel & lodging$63,3116%
  • Food & beverage$15,6591%
  • Ownership interest$1,9740%
  • Other$9,0411%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)395$828,169
Philips North America LLC9$137,446
Braemar Manufacturing, LLC2$130,012
Boston Scientific5$19,763
Biotronik Inc.12$13,226
Topera, Inc.3$11,015
Abbott1$148
Biosig Technologies, Inc.1$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,139,808 in reported general payments places this provider in the 95th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$125,870
Medicare patients
370
Services billed
2,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban598$721,845
XareltoRivaroxaban104$136,467
MultaqDronedarone Hcl32$36,438
EntrestoSacubitril/Valsartan21$21,220
Dofetilide97$16,261
Metoprolol Succinate394$6,660
Diltiazem 24hr Er (Cd)Diltiazem Hcl122$4,475
Flecainide Acetate90$3,770
Amiodarone Hcl127$3,446
Mexiletine Hcl21$1,868
SotalolSotalol Hcl51$1,414
Warfarin Sodium66$766
Verapamil ErVerapamil Hcl18$675
Enalapril Maleate26$669
Carvedilol73$562

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →